EGFR and lung adenocarcinoma: Accumulating evidence demonstrated that mutations of EGFR were identified in 15–30% of lung adenocarcinomas in Caucasians [11] and 40–60% in East Asians [12–14], indicating that the frequency of activated mutations of EGFR depends on ethnicity.